Guo Dai
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: June 15, 2018
Lon Peptidase 2, Peroxisomal (LONP2) Contributes to Cervical Carcinogenesis via Oxidative Stress.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: March 05, 2018
Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Journal: Molecular carcinogenesis
Published: January 22, 2018
Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: September 04, 2017
miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2.
Journal: Scientific reports
Published: August 22, 2017
MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1.
Journal: Oncology letters
Published: August 21, 2017
Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells.
Journal: Scientific reports
Published: March 09, 2017
miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1.
Journal: Cancer cell international
Published: December 03, 2016
Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling.
Journal: European journal of pharmacology
Published: August 21, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026